Drugs Molecular Biology RNA 
DrugBank
MAY 15, 2024
The road to developing effective drugs is fraught with both promise and challenge, particularly when it comes to what scientists call "undruggable" targets. The Evolution of Drug Discovery: From Dark Rooms to Precision Targets In the past, drug discovery often felt like a lucky guess.
The Pharma Data
FEBRUARY 25, 2022
Several FDA-approved drugs – including for type 2 diabetes, hepatitis C and HIV – significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. 25) in the journal Communications Biology. 25) in the journal Communications Biology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
DECEMBER 7, 2023
Phage have been of interest to scientists as tools to understand fundamental molecular biology, as vectors of horizontal gene transfer and drivers of bacterial evolution, as sources of diagnostic and genetic tools, and as novel therapeutic agents. He continued: “CBASS cyclases look a lot like cGAS, so they have to be sensing something.
Elrig
APRIL 29, 2024
Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?
Broad Institute
JANUARY 30, 2024
In his lab at the Broad Institute of MIT and Harvard , he uses genomic technology to explore how bacteria become drug-resistant, to study how the immune system goes awry in sepsis, and to develop new molecular diagnostic approaches for bacterial infections. million deaths attributed directly to resistant infections.
The Pharma Data
NOVEMBER 10, 2021
By creating genetically finagled mouse models and doing single cell RNA-sequencing, Feng and associates plant that Shp2 was needed by excrescence cells for HCC development, which validated and corroborated allowing that Shp2 presented an ideal target for new cancer curatives. ” Source link: [link].
Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. Last stops at RNA My last roles in biotech were where my original passion began: DNA and RNA.
Expert insights. Personalized for you.
81 
Let's personalize your content